Data as of Apr 17
| -0.10 / -0.25%|
The 1 analysts offering 12-month price forecasts for Anika Therapeutics Inc have a median target of 60.00, with a high estimate of 60.00 and a low estimate of 60.00. The median estimate represents a +52.94% increase from the last price of 39.23.
The current consensus among 2 polled investment analysts is to Buy stock in Anika Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.